Med Fusion Revenue and Competitors

med fusion is assisting colleagues within the healthcare community to redefine the delivery of clinical laboratory and clinical trials services in a patient-centric model that uniquely integrates these services for the healthcare providers they support. med fusion is working to change expectations for laboratory services and clinical trials. The result: More targeted diagnostics, improved episodes of patient care and enhanced system efficiencies.OUR COMPANY med fusion has created a new, patient-centric support model for medicine, integrating advanced laboratory services and clinical trials services to support both healthcare providers and biotech/pharmaceutical companies. This holistic approach facilitates more effective and efficient patient care, greater access to integrated information and technology and increases collaboration with clinicians. In short, med fusion works with healthcare institutions to help optimize the service they provide. Headquartered in Lewisville, Texas, med fusion includes a 130,000 square foot facility (projected to expand to 500,000 square feet). med fusion has dedicated medical and scientific staff to help answer questions and lead test development as well as validation teams to quickly meet the needs of clients. med fusion currently has over 200 employees and is growing rapidly. Our well-trained and dedicated lab staff has on average of over 16 years experience. This convergence of laboratory services, clinical research data and patient care support offers many benefits: Patient laboratory reports are more integrated and take into consideration patient histories to support physicians in their quest for exact information that allows them to form more targeted diagnoses and recommend more specific treatments. Patient information in support of clinical trials is delivered rapidly to support physicians as they determine enrollment criteria. The new model narrows the gap between diagnostic testing and therapeutic development, supporting the process of getting new therapies and clinically validated tests to market quicker.